Skip to main content

Table 3 Characteristics of the patients who completed the questionnaire

From: Patient satisfaction and amenorrhea rate after endometrial ablation by ThermaChoice III or NovaSure: a retrospective cohort study

 

NovaSure

ThermaChoice III

p value

199 patients

130 patients

Age (years)

43.1 ± 4.5

42.2 ± 4.6

0.081

Parity

1.9 ± 1.1

2.3 ± 1.3

0.008

Body mass index (kg/m2)

26.0 ± 4.4

26.5 ± 5.7

0.366

Anticoagulantia

13 (7)

7 (5)

0.670

Coagulopathie

1 (1)

7 (5)

0.007

Flushes

51 (26)

32 (25)

0.901

Previous treatments for HMB

138 (69)

105 (81)

0.021

 >1 previous treatments

53 (27)

50 (39)

0.024

 LNG-IUS

65 (33)

57 (44)

0.040

 Oral contraceptives

99 (50)

63 (49)

0.819

 Other drugs

34 (17)

39 (30)

0.006

 Endometrial ablation

1 (1)

7 (5)

0.005

Number of myomata

0.3 ± 0.8

0.3 ± 0.7

0.909

 Size of myoma (mm)

22.2 ± 10.1

21.8 ± 10.5

0.884

 Subsereus

10 (5)

7 (5)

0.859

 Intramuraal

22 (11)

16 (13)

0.701

 Submuceus

5 (3)

1 (1)

0.410

Sound length (cm)

9.1 ± 1.0

8.9 ± 1.1

0.236

Filling balloon (ml)

 

20.3 ± 11.4

 

Power (W)

98.9 ± 27.9

  

Duration of current (s)

97.6 ± 19.9

  
  1. Mean ± standard deviation or frequency (%). Other drugs = goserelin, leuprorelin, lynestrenol, medroxyprogesteron, norethisterone, and transexamic acid
  2. HMB heavy menstrual bleeding, LNG-IUS levonorgestrel-intrauterine system
  3. p-value < 0.05 was considered significant